EMA Publishes Action Plan to Streamline Gene Therapy Development and Review

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency launched a new plan to streamline procedures for developing advanced gene and cell therapies, including adapting manufacturing requirements to products’ specific challenges.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor